Elixir: Elixir's DynamX bioadaptor obtains FDA breakthrough designation

Elixir Medical has received breakthrough device designation from the US Food and Drug Administration (FDA) for its DynamX Sirolimus-Eluting Coronary Bioadaptor System. The post Elixir's DynamX bioadaptor obtains FDA breakthrough designation appeared first on Medical Device Network.